rs397517584
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_001267550.2(TTN):c.46069_46070delAT(p.Met15357ValfsTer4) variant causes a frameshift change. The variant allele was found at a frequency of 0.000000685 in 1,460,326 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001267550.2 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.46069_46070delAT | p.Met15357ValfsTer4 | frameshift_variant | Exon 248 of 363 | ENST00000589042.5 | NP_001254479.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.46069_46070delAT | p.Met15357ValfsTer4 | frameshift_variant | Exon 248 of 363 | 5 | NM_001267550.2 | ENSP00000467141.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460326Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 726460
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Primary dilated cardiomyopathy Pathogenic:1
The Met12789fs variant in the TTN gene has not been reported in the literature b ut has been identified by our laboratory in one individual with DCM and in four unaffected relatives. The presence of this variant in four unaffected relatives suggests that it may have a reduced penetrance or that other genetic or environm ental factors may be contributing to disease in this family. The Met12789fs vari ant is predicted to cause a frameshift, which alters the protein's amino acid se quence beginning at codon 12789 and leads to a premature stop codon 4 amino acid s downstream. This alteration is then predicted to lead to a truncated or absent protein (loss of function). Loss of function variants in TTN are common in pati ents with DCM (Herman 2012). In summary, the severity of the impact to the prote in as well as the high prevalence of loss of function variants in patients with DCM suggests that this variant is likely to be pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at